GIM
REGN icon

Gyrus Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Gyrus Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,875
Closed -$1.3M – 68
2015
Q1 		$1.3M Sell
2,875
-2,100
-42% -$890K 0.22% 95
2014
Q4 		$2.04M Sell
4,975
-975
-16% -$383K 0.34% 87
2014
Q3 		$2.15M Sell
5,950
-200
-3% -$67K 0.38% 86
2014
Q2 		$1.74M Sell
6,150
-25
-0.4% -$7.41K 0.31% 91
2014
Q1 		$2.05M Sell
6,175
-200
-3% -$61.6K 0.36% 90
2013
Q4 		$1.86M Buy
6,375
+3,375
+113% +$971K 0.39% 79
2013
Q3 		$965K Buy
+3,000
New +$789K 0.21% 91

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Gyrus Investment Management's REGN Position: Q2 2015 in Review

Gyrus Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2015, closing a stake of 2,875 shares — an estimated $1.3M sold.

Gyrus Investment Management first reported a position in REGN in Q3 2013 and held it in 7 quarters. The position peaked at $2.15M in Q3 2014. 541 funds tracked by Wall St. Rank hold REGN as of Q2 2015.

  • Gyrus Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Gyrus Investment Management sold 2,875 Regeneron Pharmaceuticals shares in Q2 2015, an estimated $1.3M.
  • Gyrus Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Gyrus Investment Management's Regeneron Pharmaceuticals position peaked at $2.15M in Q3 2014.
  • 541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2015.

Based on Gyrus Investment Management's 13F filing for Q2 2015.